Wessel Tadd S.

Wessel Tadd S. is listed in filings as Director at Palvella Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 11, 2025, including 2 public disclosures. Recent filings connect the profile to Palvella Therapeutics, Inc. (PVLA). The current snapshot covers public activity from Dec 17, 2024 to Jun 11, 2025. Reported amounts are shown as $335.9K to $323.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.